Fosfomycin Oral Sachets Or Powder For Suspension Suppliers & Bulk Manufacturers
Available Forms: Oral Sachets or Powder for Suspension
Available Strengths: 3g in a sachet
Reference Brands: Zyflo(US)
Category:
Antibiotics
Fosfomycin inhibits bacterial cell wall synthesis by targeting MurA, preventing peptidoglycan formation. Its oral sachets or powder for suspension offer broad-spectrum activity against resistant bacteria, especially in urinary tract infections. Benefits include effective, once-daily dosing, rapid bacterial eradication, minimal resistance development, and suitability for outpatient or pediatric use.
Fosfomycin Oral Sachets or Powder for Suspension is available in Oral Sachets or Powder for Suspension
and strengths such as 3g in a sachet.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fosfomycin Oral Sachets or Powder for Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fosfomycin Oral Sachets or Powder for Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fosfomycin oral sachets and powder for suspension are approved in the EU and US for uncomplicated urinary tract infections. In the EU, brands like Fosfomycin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generics are available. Both regions require detailed dossiers including clinical trial results, quality documentation, and pharmacovigilance plans for approval and safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for fosfomycin oral formulations, ensuring adherence to European and US standards for safe and effective outpatient antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing